GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Inc (NAS:IXHL) » Definitions » Cyclically Adjusted Book per Share

IXHL (Incannex Healthcare) Cyclically Adjusted Book per Share : $0.95 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Incannex Healthcare Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Incannex Healthcare's adjusted book value per share for the three months ended in Sep. 2024 was $0.374. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.95 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -63.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -52.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Incannex Healthcare was -22.60% per year. The lowest was -63.20% per year. And the median was -38.10% per year.

As of today (2024-12-12), Incannex Healthcare's current stock price is $1.77. Incannex Healthcare's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was $0.95. Incannex Healthcare's Cyclically Adjusted PB Ratio of today is 1.86.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Incannex Healthcare was 2.92. The lowest was 1.57. And the median was 2.03.


Incannex Healthcare Cyclically Adjusted Book per Share Historical Data

The historical data trend for Incannex Healthcare's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Cyclically Adjusted Book per Share Chart

Incannex Healthcare Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.61 19.59 9.97 3.65 0.98

Incannex Healthcare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.30 1.30 0.98 0.95

Competitive Comparison of Incannex Healthcare's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incannex Healthcare's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's Cyclically Adjusted PB Ratio falls into.



Incannex Healthcare Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Incannex Healthcare's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.374/129.1850*129.1850
=0.374

Current CPI (Sep. 2024) = 129.1850.

Incannex Healthcare Quarterly Data

Book Value per Share CPI Adj_Book
201412 3.274 99.002 4.272
201503 0.000 99.187 0.000
201506 0.526 99.838 0.681
201509 0.000 100.302 0.000
201512 0.205 100.673 0.263
201603 0.000 100.488 0.000
201606 -0.201 100.859 -0.257
201609 0.000 101.602 0.000
201612 0.712 102.159 0.900
201703 0.000 102.624 0.000
201706 -0.075 102.809 -0.094
201709 0.000 103.460 0.000
201712 0.109 104.110 0.135
201803 0.000 104.574 0.000
201806 -0.089 104.945 -0.110
201809 0.000 105.410 0.000
201812 0.047 105.967 0.057
201903 0.000 105.967 0.000
201906 -0.050 106.617 -0.061
201909 0.000 107.174 0.000
201912 0.515 107.917 0.616
202003 0.000 108.289 0.000
202006 0.290 106.246 0.353
202009 0.000 107.917 0.000
202012 0.872 108.846 1.035
202103 0.000 109.496 0.000
202106 0.603 110.332 0.706
202109 0.000 111.168 0.000
202112 1.168 112.654 1.339
202203 0.000 115.069 0.000
202206 1.909 117.112 2.106
202209 0.000 119.248 0.000
202212 4.194 121.477 4.460
202303 0.000 123.148 0.000
202306 1.312 124.170 1.365
202309 0.000 125.656 0.000
202312 1.189 126.399 1.215
202403 0.891 127.606 0.902
202406 0.636 128.906 0.637
202409 0.374 129.185 0.374

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Incannex Healthcare  (NAS:IXHL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Incannex Healthcare's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.77/0.95
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Incannex Healthcare was 2.92. The lowest was 1.57. And the median was 2.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Incannex Healthcare Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare Business Description

Traded in Other Exchanges
N/A
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.